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Abstract We investigated whether application of non-distend-
ing hydrostatic pressure facilitates gene transfer into vein grafts.
An external jugular vein was placed in a chamber with 100 Wl
adenovirus solution at a titer of 1010 pfu/ml and was pressurized
to up to 8 atm above ambient pressure for 10 min. Histochemical
analysis demonstrated a positive transgene expression in all
layers of the vessel wall. Gene transfer with 8 atm pressurization
resulted in an approximately 50 times higher transgene expres-
sion than that without pressurization. Under 8 atm pressuriza-
tion, the efficiency of gene transfer reached a plateau at 7.5 min.
The application of hydrostatic pressure may improve the
effectiveness of intraoperative genetic engineering of vein grafts.
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1. Introduction
Vein grafts are utilized as a conduit for aortocoronary by-
pass grafting to improve myocardial £ow and for vein graft-
covered stents to manage perforated bypass-grafts [1] or na-
tive vessels [2]. However, there would seem to be potential
problems in vein grafts, such as thrombosis and neointimal
hyperplasia [3]. Replication-de¢cient adenovirus is a useful
tool to introduce exogenous genes to control vascular re-
sponses in pathophysiological states [4,5]. It was recently re-
ported that the application of hydrostatic pressure facilitates
the delivery of oligodeoxynucleotide into cardiovascular tis-
sues [6]. In the present study, we characterize the e¡ect of
pressurization during ex vivo adenovirus gene transfer to
vein grafts. In vivo transgene expression in infected autolo-
gous vein grafts will also be discussed.
2. Materials and methods
All experiments followed a protocol approved by the Animal Re-
search Committee of the University of Tokyo.
2.1. Experimental animal preparation and pressure-supported gene
transfer
Male Japanese white rabbits (2000^3000 g) were used for the
present study. After the induction of anesthesia (pentobarbital, 50
mg/kg, i.v., and ketamine, 50 mg/kg, i.m.), the left external jugular
vein was carefully dissected out. Each vein graft was then mounted
onto a Palmaz^Schatz stent (Johnson and Johnson). Vein grafts were
then placed in a custom-made small chamber (Medikit) with 100 Wl
adenovirus solution dissolved in Dulbecco’s modi¢ed Eagle’s medium
(DMEM, Gibco) for up to 10 min under up to 8 atm above ambient
pressure by using a standard angioplasty in£ation device (Encore,
Scimed). The vein segment was surrounded by pressurized viral solu-
tion both luminally and abluminally, thereby avoiding distension or
stretch of the vessel wall. Vein grafts were subsequently incubated in
Medium 199 (M199, Gibco) supplemented with 10% fetal calf serum
(FCS) for a further 48 h to allow the expression of transferred genes
at the protein level. In some experiments, three sutures (Prolene 8-0,
Ethicon) were applied at each side of the stent to stabilize the vein
graft on the stent strut before gene transfer. An autologous vein graft-
covered stent was implanted into the abdominal aorta immediately
after the gene delivery using a standard angioplasty balloon cathe-
ter/guide wire (0.014 inch) system. Animals were killed 48 h after the
stent implantation and expression of the transferred gene was exam-
ined.
2.2. Recombinant adenoviruses
Two replication-de¢cient, second generation recombinant adenovi-
rus constructs were made and puri¢ed as described previously [7]. Ad-
HO-1 and Ad-LacZ encode a rat heme oxygenase-1 (HO-1, a kind gift
from Dr. S. Shibahara, Tohoku University School of Medicine, Ja-
pan), and an Escherichia coli lacZ, respectively. The cDNAs in these
vectors were driven under the control of cytomegalovirus immediate
early gene enhancer and promoter.
2.3. Histochemical analysis
For the histochemical analysis of L-galactosidase expression, gross
vein specimens or fresh frozen sections (5 Wm thick) of the vein seg-
ments mounted on silanized slides were ¢xed in 0.2% glutaraldehyde
for 10 min and stained for 16 h in X-Gal chromogen as described
previously [8].
2.4. Protein puri¢cation and immunoblot analysis
Puri¢cation of the protein from the vein samples was carried out
following the protocol described elsewhere [9]. Anti-HO-1 monoclonal
antibody (OSA 111, StressGen) and horseradish peroxidase-conju-
gated anti-mouse antibody (Jackson ImmunoResearch) was used at
1/1000 and 1/2000 dilutions, respectively. The ECL Western blotting
system (Amersham Life Sciences) and lumino-analyzer (Fuji Photo
Film) were used for detection of bands. The intensity of bands was
semi-quanti¢ed using computer software, NIH Image.
2.5. Cell culture and pressure-supported gene transfer to cultured cells
Rabbit aortic vascular smooth muscle cells (VSMCs) were isolated
from the thoracic aorta of male Japanese white rabbits using the
methods described previously [10]. Cells were grown in DMEM sup-
plemented with 10% FCS, 100 U/ml penicillin and 100 Wg/ml strepto-
mycin. After trypsinization of the cells, cells (1U105) were placed in
the same chamber with 100 Wl adenovirus solution (1U106^3U109
pfu/ml) dissolved in DMEM for 10 min under 8 atm above ambient
pressure by using the standard angioplasty in£ation device as de-
scribed above. The cells were then seeded on to the collagen type 1
cover glass with a diameter of 12 mm (Iwaki), which was placed in a
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Fig. 1. Macroscopic and light microscopic views of vein segments that had been subjected to pressure-supported ex vivo adenovirus-mediated
gene transfer followed by en face X-Gal staining. Vein segments were infected with either Ad-LacZ (A and B, lower panels, D^G, I^O, Q, R
and S) or Ad-HO-1 (A and B, upper panels, C, H, P and T). X-Gal staining of vein segments was performed 48 h after incubation with adeno-
viruses at a titer of 1010 pfu/ml under 8 atm for 5 min (D, E, I and J) and 10 min (A^C, F^H, K^T). A and B: En face macroscopic images
of gross vein specimen (A) and the adventitial surface of longitudinally opened vein grafts (B). C^L: En face light microscopic views using lon-
gitudinally opened vein segments. Views from the luminal (C^G) and from the adventitial side (H^L) are shown. M^T: X-Gal staining of the
frozen sections of vein grafts. After gene transfer, vein grafts were organ cultured in M199 or implanted into abdominal aorta (Q^T). Vein
grafts were harvested 48 h after the gene transfer. N and O are magni¢ed views of left and right bracketed regions in M, respectively, and R
and S are magni¢ed views of upper and lower bracketed regions in Q, respectively. Lum and Adv indicate the luminal surface and the adventi-
tia, respectively. Original magni¢cations U250 (C, D, F, H, I, K, M, P and Q) and U800 (E, G, J, L, N, O, R, S and T).
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24 well plate, together with the adenovirus solution. Five minutes
after seeding the cells onto the cover glass, cells were washed three
times with DMEM to remove adenovirus in the culture medium. Then
the cells were incubated in DMEM supplemented with 10% FCS for a
further 48 h to allow expression of the transferred genes at the protein
level. After ¢xing the cells in 0.2% glutaraldehyde for 10 min, the
expression of L-galactosidase was examined.
2.6. Statistical analysis
Data are expressed as mean þ S.E.M. ANOVA followed by a multi-
ple comparison test was used for comparisons on the initial data
before expression as a percentage of the control using the statistical
analysis software, Statistica ver. 5.1J (StatSoft Inc.). A value of
P6 0.05 was considered to be statistically signi¢cant.
3. Results and discussion
3.1. Adenovirus-mediated transfer of lacZ genes
L-Galactosidase expression was examined histochemically
48 h after ex vivo adenovirus-mediated gene transfer at a titer
of 1010 pfu/ml under 8 atm for 10 min. Marked L-galactosi-
dase expression was observed in the vein grafts infected with
Fig. 2. E⁄ciency of pressure-supported adenovirus-mediated gene transfer. Rabbit jugular vein segments were subjected to adenovirus-mediated
gene transfer of the indicated gene, at the indicated concentrations for the indicated length of time. Pressure dose^response (A, D), time course
(B, E) and viral titer^response (C, F) data are shown. Expression of rat HO-1 was examined using anti-HO-1 mAb (OSA 111). A^C: represen-
tative immunoblots. D^F: relative intensity of HO-1 bands in comparison with the intensity of the HO-1 bands in the samples infected with
Ad-HO-1 at a titer of 1010 pfu/ml for 10 min at 8 atm was calculated. Data from 4^6 samples in each point are summarized in line graphs.
*P6 0.01 and 2P6 0.001 versus samples from vein segments infected with 1010 pfu/ml Ad-HO-1 at 8 atm for 10 min.
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Ad-LacZ (Fig. 1A,B, lower panels), but not in those infected
with Ad-HO-1 (Fig. 1A,B, upper panels). A 10 min incubation
with Ad-LacZ solution seemed to result in more L-galactosi-
dase expression (Fig. 1F,G,K,L) than a 5 min incubation with
the viral solution (Fig. 1D,E,I,J) under 8 atm.
X-Gal staining of the frozen sections of vein segments sub-
jected to ex vivo Ad-LacZ gene transfer showed L-galactosi-
dase expression in cells of all layers of the venous wall (Fig.
1M^O). Positive signals were detected in the medial smooth
muscle cells in a dotted fashion (Fig. 1O, arrowhead). No
Fig. 3. E⁄ciency of pressure-supported gene transfer at a higher concentration and e⁄ciency of gene pressure-supported gene transfer to cul-
tured smooth muscle cells. A^D: E⁄ciency of pressure-supported gene transfer at a titer of 1011 pfu/ml. Rabbit jugular vein segments were sub-
jected to gene transfer of Ad-HO-1, at the indicated concentrations for the indicated length of time. Pressure dose^response (A, C) and time
course (B, D) data are shown. Expression of rat HO-1 was examined using anti-HO-1 mAb (OSA 111). A and B: Representative immunoblots.
C and D: Relative intensity of HO-1 bands in comparison with the intensity of the HO-1 bands in the samples infected with Ad-HO-1 at a
titer of 1010 pfu/ml for 10 min at 8 atm was calculated. Data from 4^6 samples in each point are summarized in line graphs. *P6 0.05 and
2P6 0.001 versus samples from vein segments infected with 1011 pfu/ml Ad-HO-1 at 8 atm for 10 min. E: e¡ect of pressurization on gene
transfer to cultured VSMCs. VSMCs were incubated with Ad-LacZ at the indicated concentrations with or without pressurization under 8 atm
for 10 min. X-Gal staining was performed 48 h after gene transfer. Representative photograph of two independent experiments with similar re-
sults is shown.
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staining was observed in the vein graft infected with Ad-HO-
1. A relatively higher transgene expression in the adventitial
cells in the vessel wall was compatible to the previous ¢nding
[11]. We also investigated in vivo gene expression of vein
graft-covered stents after implantation into abdominal aortas.
In the in vivo situation, positively stained cells lining the lu-
minal surface had been lost (Fig. 1Q), which may have been
caused by balloon in£ation during stent delivery or by expo-
sure to the arterial circulation. On the other hand, positively
stained cells in the medial (Fig. 1R, arrowheads) and adven-
titial (Fig. 1S) layers could be observed. Hematoxylin eosin
staining of the specimens showed no apparent injury in pres-
sure-subjected vessel wall (Ishizaka, unpublished observation).
3.2. Semi-quantitative analysis of the e⁄ciency of gene transfer
of Ad-HO-1
To evaluate the factors in£uencing the e⁄ciency of pres-
sure-supported gene transfer, the expression of rat HO-1
was investigated by immunoblot analysis. In a preliminary
study, we tested two monoclonal anti-HO-1 antibodies,
OSA111 and clone 23 (Transduction Laboratory), and found
that the former detects rat HO-1 but not rabbit HO-1 and the
latter detects rabbit HO-1 but not rat HO-1 (data not shown).
Therefore, we used OSA111 to assess the e⁄ciency of gene
transfer of Ad-HO-1, which carries the rat HO-1 sequence, in
a semi-quantitative manner.
HO-1 expression increased with increasing pressure and did
not reach a plateau even at 8 atm (Fig. 2A,D). In the vein
segments subjected to Ad-HO-1 infection (1010 pfu/ml, 8 atm,
10 min), the expression of endogenous (rabbit) HO-1 was
markedly downregulated compared to non-infected controls
(data not shown). Longer durations from 1 to 10 min yielded
greater HO-1 expression, but these e⁄ciencies were not fur-
ther increased at 7.5 min (Fig. 2B,E). Increasing viral titers
from 3U108 to 1010 pfu/ml yielded greater transfection e⁄-
ciencies under 8 atm (Fig. 2C,F).
We then examined the e⁄ciency of Ad-HO-1 infection at a
titer of 1011 pfu/ml. As shown in Fig. 3, HO-1 expression was
approximately three times higher in the veins subjected to Ad-
HO-1 infection at a titer of 1011 pfu/ml than in those sub-
jected to Ad-HO-1 infection at a titer of 1010 pfu/ml. HO-1
expression increased with increasing pressure, but these e⁄-
ciencies were not further increased at 4 atm (Fig. 3A,C). Lon-
ger durations from 1 to 10 min yielded greater HO-1 expres-
sion, but these e⁄ciencies did not reach a plateau even at 10
min (Fig. 3B,D).
3.3. Adenovirus-mediated transfer of lacZ genes to cultured
VSMCs
Finally, in order to gain insight into the mechanisms of
pressure-induced facilitation of adenovirus gene transfer, we
performed pressure-supported Ad-LacZ infection to cultured
VSMCs ??using the same pressurization system. There were
no obvious di¡erences in the X-Gal staining between the cells
with pressurization and without pressurization during gene
transfer (Fig. 3E). This ¢nding suggests that pressure-induced
facilitation of gene transfer to vein segments was not due to
the change of the physical properties of membrane of vascular
cells, but due to the increased in¢ltration of the virus particle
toward the target cells.
Two ¢ndings may be of note in the present study in con-
sideration of their clinical utility. First, the e⁄ciency of ad-
enovirus-mediated gene delivery to vein grafts did not reach a
plateau even at 8 atm. Previous work demonstrated that the
application of pressures of several atmospheres at the time of
in vivo gene transfer causes extensive vessel wall damage [12].
In the present study, however, hydrostatic and non-distending
pressure was applied evenly along the entire vessel, thereby
minimizing damage to the vascular cells, since this range of
hydrostatic pressure is applied in hyperbaric treatment or in
diving and is, therefore, considered ‘physiological’ [13]. Sec-
ond, the e⁄ciency of adenovirus transfer (1010 pfu/ml)
reached a plateau at 7.5 min under 8 atm hydrostatic pressure.
This relatively short duration of incubation period compared
to previous studies [14,15] may increase the feasibility of ex-
ploiting intraoperative adenovirus-mediated gene transfer as a
potential therapeutic strategy at the time of bypass grafting,
for example by using vein graft as a conduit and implantation
of vein graft-covered stents.
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